Organigram Global Inc.

NASDAQ:OGI

Drug Manufacturers - Specialty & Generic

Healthcare
$0.68 -1.74%

-$0.02 today

Market cap
$95.40M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $0.97High $2.24

Volume 0.62M

Average 0.67M

OGI Net Change in Cash

Combined operating, investing, financing, and currency effects on the cash balance during the period.

Organigram Global Inc.NASDAQ: OGI

Net Change in Cash · Q2 FY2026 · quarter ended Mar 2026

Net change in cash turns negative

Q2 FY2026 net change in cash was -CA$9.04M, compared with CA$13.82M a year earlier. Trailing-twelve-month net change in cash was -CA$29.19M.

Context

  • Net change in cash amounted to 20.4% of revenue in FY2025, down 25.2 pp from a year earlier.
  • Net change in cash increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly net change in cash holds near -CA$9.04M or moves back toward the trailing-twelve-month quarterly average of -CA$7.3M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-CA$9.04M-55.3% QoQ
Last fiscal yearSep 2025
-CA$37.98M-152.1% YoY
LTMMar 2026
-CA$29.19M+92.5% YoY
Net Change in Cash past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-165.5%——
1 year-152.1%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Net Change in Cash history

CAD · from the cash flow

Latest · FY2025
(37.98M) CAD
Year-over-year change
-152.1%

Net Change in Cash vs competitors

How OGI compares with its peers on the latest reported figures

  • Peers report in different currencies, so net change in cash is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +92.5% is the 4th highest of 9, against a peer median of -31.3%.
  • Net change in cash amounts to 10.6% of revenue for OGI, versus a peer median of 23.4%.
OGI Competitors
Net Change in Cash for OGI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ACBAurora Cannabis Inc.LTM Mar 2026CA$72.73M CAD-396.2%-21.9%23.4%
RNACCartesian Therapeutics, Inc.LTM Mar 2026$61.73M USD-179.8%+127.8%3477.6%
OGIOrganigram Global Inc.LTM Mar 2026CA$29.19M CAD+92.5%—10.6%
IVAInventiva S.A.FY2025€14.17M EUR-79.7%+326.2%316.0%
OBIOOrchestra BioMed Holdings, Inc.LTM Mar 2026$10.02M USD+301.3%+8.1%30.6%
DERMJourney Medical CorporationLTM Mar 2026$6.15M USD+305.9%—9.5%
LFCRLifecore Biomedical, Inc.LTM Mar 2026$3.42M USD——2.5%
HSDTSolana CompanyLTM Mar 2026$3.29M USD+229.9%+20.5%34.3%
ELMDElectromed, Inc.LTM Mar 2026$1.75M USD-50.4%-40.3%2.4%
INFUInfuSystem Holdings, Inc.LTM Mar 2026$600K USD-12.3%—0.4%
Peer median (excluding OGI) —-31.3%+14.3%23.4%

Competitors are the stored peer set for OGI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Net Income(130.7M)(14.28M)(229.48M)(45.44M)(24.76M)
Depreciation & Amortization31.03M24.91M24.08M12.08M17.98M
Deferred Income Tax42.21M(88K)(2.66M)0(13.77M)
Stock-Based Compensation3.9M5.13M5.29M7.18M4.22M
Change in Working Capital24.2M(22.88M)12.51M14.96M(2.12M)
Accounts Receivables(6.01M)(24.02M)12.51M(12.06M)(15.29M)
Inventory28.68M(12.22M)000
Accounts Payables2.06M12.15M000
Other Working Capital(542K)1.21M(4.06M)27.02M13.16M
Other Non-Cash Items776K(29M)151.8M15.09M14.16M
Operating Cash Flow(28.59M)(36.21M)(35.8M)3.87M(4.3M)
Capital Expenditures(12.33M)(48.78M)(26.9M)(5.34M)(12.22M)
Acquisitions (Net)(2.54M)(11.06M)00(65.62M)
Purchases of Investments(120.02M)(15M)(7.36M)(29.24M)(1.01M)
Sales of Investments50.85M114.59M36.37M3.52M2.5M
Other Investing Activities(31.08M)4.29M31.46M(8.32M)21.8M
Investing Cash Flow(115.11M)44.03M4.56M(38.77M)(59.35M)
Debt Repayment(116.4M)(1.01M)(64.04K)(786K)(43.08K)
Common Stock Issued284.88M6.34M20K108.56M29.57M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities5.99M6.34M(754.15K)6K(1.29M)
Financing Cash Flow174.46M5.33M(754.15K)107.78M28.24M
Effect of Forex Changes0000(2.57M)
Net Change in Cash30.77M13.15M(68.52M)72.88M(37.98M)
Free Cash Flow(40.92M)(84.99M)(62.7M)(1.47M)(16.52M)

Organigram Global Inc.

NASDAQ:OGI

Intrinsic Alpha fair value

Locked

Current Price

$0.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.